Abiopharma

(30% Negative) BEAM THERAPEUTICS INC. (BEAM) Reports Q2 2026 Financial Results

(30% Negative) 1 800 FLOWERS COM INC (FLWS) Reports Q2 2026 Financial Results

Gilat to Present at Upcoming Investor Conferences

(10% Negative) AKEBIA THERAPEUTICS, INC. (AKBA) Reports Q2 2026 Financial Results

(30% Negative) CARECLOUD, INC. (CCLD) Reports Q2 2026 Financial Results

(75% Positive) ZOETIS INC. (ZTS) Reports Q2 2026 Financial Results

(10% Negative) DATADOG, INC. (DDOG) Reports Q2 2026 Financial Results

(30% Negative) BLACKSKY TECHNOLOGY INC. (BKSY) Reports Q2 2026 Financial Results

(99% Neutral) COOPER-STANDARD HOLDINGS INC. (CPS) Reports Q2 2026 Financial Results

(30% Negative) TECNOGLASS INC. (TGLS) Reports Q2 2026 Financial Results

(30% Negative) MONTE ROSA THERAPEUTICS, INC. (GLUE) Reports Q2 2026 Financial Results

(30% Negative) MYERS INDUSTRIES INC (MYE) Reports Q2 2026 Financial Results

(30% Negative) CLIMB BIO, INC. (CLYM) Reports Q2 2026 Financial Results

(30% Negative) VITAL FARMS, INC. (VITL) Reports Q2 2026 Financial Results

Ironwood - Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance